Article information
Full text is only aviable in PDF
Bibliografía
[1.]
V. Sobradillo, M. Miravitlles, C.A. Jiménez, R. Gabriel, J.L. Viejo, J.F. Masa, et al.
Estudio IBERCOP en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo.
Arch Bronconeumol, 35 (1999), pp. 159-166
[2.]
C. Villasante, M. Miravitlles, C.A. Jiménez, R. Gabriel, J.L. Viejo, J.F. Masa, et al.
Underdiagnosis and undertreatment of COPD in Spain.
Eur Respir J, 14 (1999), pp. S214
[3.]
A.D. López, C.C. Murray.
The global burden of diseases, 1990- 2020.
Nat Med, 4 (1999), pp. 1241-1243
[4.]
American Thoracic Society.
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 152 (1995), pp. S77-S121
[5.]
British Thoracic Society.
Guidelines for the management of chronic obstructive pulmonary disease.
Thorax, 52 (1997), pp. S1-S28
[6.]
J.A. Barberá, G. Peces-Barba, A.G.N. Agusti, J.L. Izquierdo, E. Monsó, T. Montemayor, et al.
Normativa SEPAR. Guía clínica para el diagnóstico y el tratamiento de la enfermedad pulmonar obstructiva crónica.
Arch Bronconeumol, 37 (2001), pp. 297-316
[7.]
C. Fletcher, R. Peto.
The natural history of chronic airway obstruction.
Bmj, 1 (1977), pp. 1645-1648
[8.]
N.R. Anthonisen.
Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials.
Am Rev Respir Dis, 133 (1989), pp. 95-99
[9.]
C.A.J. Katelaars, M.A. Schlösser, R. Mostert, H. Huyer Abu-Saad, R.J.G. Halfens, E.F.M. Wouters.
Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease.
Thorax, 51 (1996), pp. 39-43
[10.]
D.W. Mapel, J.S. Hurley, F.J. Frost, H.V. Petersen, M.A. Picchi, D.B. Coultas.
Health Care utilization in chronic obstructive pulmonary disease.
Arch Intern Med, 160 (2000), pp. 2653-2658
[11.]
Nocturnal Oxygen Therapy Trial Group.
Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial.
Ann Intern Med, 93 (1980), pp. 391-398
[12.]
J.E. Hodgkin.
Prognosis in chronic obstructive pulmonary disease.
Clin Chest Med, 11 (1990), pp. 555-569
[13.]
A.G.N. Agusti, J. Sauleda, M. Morlá, C. Miralles, X. Busquets.
Disfunción muscular esquelética de la EPOC. Mecanismos celulares.
Arch Bronconeumol, 37 (2001), pp. 197-205
[14.]
D. Gerardi, L. Lovett, J. Benoit-Connors.
Variables related to increased mortality following outpatient pulmonary rehabilitation.
Eur Respir J, 9 (1996), pp. 431-435
[15.]
L. Szekely, D. Oelberg, C. Wright, J. Douglas, J. Wain, B.D. Trotman, et al.
Preoperative predictors of operative mortality in COPD patients undergoing bilateral lung volume reduction surgery.
Chest, 111 (1997), pp. 550-558
[16.]
V. Pinto-plata, M. Girish, J. Tylor, B. Celli.
Natural decline in the six minute walking distance in COPD.
Am J Respir Crit Care Med, 157 (1998), pp. A20
[17.]
D. Redelmeier, A.M. Bayoumi, R.S. Goldstein, G.H. Guyatt.
Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients.
Am J Respir Crit Care Med, 155 (1978), pp. 1278-1282
[18.]
J.M. Marín Trigo.
Manifestaciones clínicas: la disnea y su importancia en el paciente con EPOC.
Arch Bronconeumol, 37 (2001), pp. 8-13
[19.]
A.L. Ries, R.M. Kaplan, T.M. Limberg, L.M. Prewitt.
Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease.
Ann Intern Med, 122 (1995), pp. 823-832
[20.]
C.G. Cote, J.M. Marin, B.R. Celli.
Factors that predict health care resources utilization in COPD.
Am J Respir Crit Care Med, 159 (1999), pp. A912
[21.]
A.N.M. Schols, J. Slangen, L. Volovics, E.F.M. Wouters.
Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 157 (1998), pp. 1791-1797
[22.]
B.R. Celli.
Monitoring the progression of chronic obstructive pulmonary disease: a time for a new staging system.
Eur Respir Rev, 9 (1999), pp. 165-168
Copyright © 2002. Sociedad Española de Neumología y Cirugía Torácica
